GlassScriptPhysician profile
Brandy T Aliotta
NPI 1427112085
$1,610.34
in general payments reported to CMS, 2019-2025
20 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $127 · 2023: $278 · 2024: $538 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.07 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $454.72 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $315.92 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $184.90 | 2021-2025 | |
| Myovant Sciences INC. | $112.97 | 2021-2022 | |
| Millicent US INC | $74.64 | 2025 | Femlyv, Femring, Intrarosa |
| Evofem Biosciences, INC. | $61.53 | 2021-2023 | Phexxi |
| Exeltis, USA INC. | $59.02 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $51.57 | 2023-2024 | Aptima |
| Mayne Pharma Commercial LLC | $49.11 | 2024-2025 | |
| Novo Nordisk INC | $38.31 | 2024-2025 | Wegovy |
| Abbvie INC. | $30.98 | 2021-2022 | |
| Teleflex LLC | $26.66 | 2025 | Quikclot |
| Smith+Nephew, INC. | $23.08 | 2024 | Pico |
| Organon LLC | $22.74 | 2023 | Nexplanon |
| Minerva Surgical, INC | $22.24 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $20.36 | 2021 | |
| Aspira Women'S Health INC | $17.62 | 2024 | Ova1 |
| Therapeuticsmd, INC. | $16.54 | 2021 | |
| Convatec INC. | $15.08 | 2025 | |
| Shield Therapeutics INC | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Aliotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.